Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC).
Visual analogue scales (VAS): Measuring instruments for the documentation of symptoms and therapy monitoring in cases of allergic rhinitis in everyday health care: Position Paper of the German Society of Allergology (AeDA) and the German Society of Allergy and Clinical Immunology (DGAKI), ENT Section, in collaboration with the working group on Clinical Immunology, Allergology and Environmental Medicine of the German Society of Otorhinolaryngology, Head and Neck Surgery (DGHNOKHC).
复制标题
DOI：
10.1007/s40629-016-0006-7
复制
发表时间：
2017
影响因子：
--
通讯作者：
Pfaar O
中科院分区：
文献类型：
--
作者：
Klimek L;Bergmann KC;Biedermann T;Bousquet J;Hellings P;Jung K;Merk H;Olze H;Schlenter W;Stock P;Ring J;Wagenmann M;Wehrmann W;Mösges R;Pfaar O
视觉模拟量表（VAS）是一种心理测量工具，旨在记录个体患者疾病相关症状严重程度的特征，并使用此来实现症状严重程度和疾病控制的快速（统计学可测量和可重现）分类。VAS还可用于常规患者病史采集和监测过敏性鼻炎（AR）等慢性疾病的病程。更具体地说，VAS已用于评估AR治疗在真实的生活中的有效性，包括间歇性和持续性疾病。本立场文件详细介绍增值服务的历史发展及其具体方法原则。特别侧重于日常生活中的实际应用方面，并对个别方法的优点和缺点进行了批判性的讨论。VAS在AR症状测量方面得到了很好的验证，与ARIA（过敏性鼻炎及其对哮喘的影响）严重程度分类相关性良好，与rTNSS和RQLQ也相关性良好。此外，几项AR治疗研究使用VAS作为评价参数。由于使用了新的（现实生活和实时）通信技术，如智能手机应用程序，讨论：VAS可以相对简单且高效地用于评估疾病控制。VAS非常适合数字化，现在已被纳入智能手机应用程序（称为过敏日记），以评估AR控制和指导治疗决策，作为AR临床决策支持系统（CDSS）的一部分。MASK Rhinitis开发了这个应用程序，目前有15种不同的语言版本。
Visual analogue scales (VAS) are psychometric measuring instruments designed to document the characteristics of disease-related symptom severity in individual patients and use this to achieve a rapid (statistically measurable and reproducible) classification of symptom severity and disease control. VAS can also be used in routine patient history taking and to monitor the course of a chronic disease such as allergic rhinitis (AR). More specifically, the VAS has been used to assess effectiveness of AR therapy in real life, both in intermittent and persistent disease. This position paper takes a detailed look at the historical development of VAS and its method-specific principles. Particular focus is put on aspects of practical application in daily routine and on a critical discussion of the advantages and disadvantages of the individual methods. VAS are well validated for the measurement of AR symptoms and correlate well with the ARIA (allergic rhinitis and its impact on asthma) severity classification and also correlated well with rTNSS and RQLQ. Moreover, several treatment studies on AR have used VAS as an evaluation parameter. Thanks to the use of new (real-life and real-time) communication technologies, such as smartphone apps, Discussion: VAS can be used relatively simply and highly effectively to assess disease control. The VAS lends itself very well to digitization and has now been incorporated into a smartphone app (called Allergy Diary) to assess AR control and direct treatment decisions as part of an AR clinical decision support system (CDSS). MASK Rhinitis has developed this app, which is currently available in 15 different languages.